{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:49:50Z","timestamp":1788346190073,"version":"build-2803163510"},"reference-count":10,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,10,1]]},"DOI":"10.1182\/blood-2015-08-662502","type":"journal-article","created":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T12:27:26Z","timestamp":1443702446000},"page":"1637-1638","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":6,"title":["MAGiC: VOC remains but kids with SCA appear"],"prefix":"10.1182","volume":"126","author":[{"given":"Jeremie Heath","family":"Estepp","sequence":"first","affiliation":[{"name":"ST. JUDE CHILDREN RESEARCH HOSPITAL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"14","key":"2019111901373839200_B1","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1182\/blood-2015-05-647107","article-title":"A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children.","volume":"126","author":"Brousseau","year":"2015","journal-title":"Blood"},{"issue":"13","key":"2019111901373839200_B2","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.2010.378","article-title":"Acute care utilization and rehospitalizations for sickle cell disease.","volume":"303","author":"Brousseau","year":"2010","journal-title":"JAMA"},{"issue":"10","key":"2019111901373839200_B3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"8","key":"2019111901373839200_B4","doi-asserted-by":"crossref","first-page":"e72077","DOI":"10.1371\/journal.pone.0072077","article-title":"Hydroxyurea use and hospitalization trends in a comprehensive pediatric sickle cell program.","volume":"8","author":"Nottage","year":"2013","journal-title":"PLoS One"},{"issue":"24","key":"2019111901373839200_B5","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1182\/blood-2013-05-498311","article-title":"Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies.","volume":"122","author":"Manwani","year":"2013","journal-title":"Blood"},{"issue":"2","key":"2019111901373839200_B6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1046\/j.1365-2141.2000.01861.x","article-title":"Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease.","volume":"108","author":"De Franceschi","year":"2000","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111901373839200_B7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2141.2007.06884.x","article-title":"Phase I study of magnesium pidolate in combination with hydroxycarbamide for children with sickle cell anaemia.","volume":"140","author":"Hankins","year":"2008","journal-title":"Br J Haematol"},{"issue":"8","key":"2019111901373839200_B8","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/pbc.24486","article-title":"Exploring barriers and facilitators to clinical trial enrollment in the context of sickle cell anemia and hydroxyurea.","volume":"60","author":"Lebensburger","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2019111901373839200_B9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nm.3814","article-title":"Anemia: progress in molecular mechanisms and therapies.","volume":"21","author":"Sankaran","year":"2015","journal-title":"Nat Med"},{"key":"2019111901373839200_B10","article-title":"2015 clinical trials update in sickle cell anemia [published online ahead of print July 15, 2015].","author":"Archer","journal-title":"Am J Hematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/14\/1637\/1388804\/1637.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/14\/1637\/1388804\/1637.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T10:13:11Z","timestamp":1718100791000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/126\/14\/1637\/34419\/MAGiC-VOC-remains-but-kids-with-SCA-appear"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,1]]},"references-count":10,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2015,10,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2015-08-662502","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,1]]}}}